Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.

PURPOSE To study whether there is a relationship between transplanted cell dose and rate of hematopoietic recovery after peripheral-blood stem-cell (PBSC) transplantation, and to obtain an indication whether specific subsets of CD34+ cell populations contribute to rapid recovery of neutrophils or platelets. PATIENTS AND METHODS Based on data from 59 patients, we calculated for each day after PBSC transplantation the dose of CD34+ cells that resulted in rapid recovery of either neutrophils or platelets in the majority (> 70%) of patients. Using dual-color flow cytometry, subsets of peripheral-blood CD34+ cells were quantified and the numbers of CD34+ cells belonging to each of the reinfused subsets correlated with hematopoietic recovery following high-dose chemotherapy. RESULTS The calculated threshold values with a high probability of engraftment showed a steep dose-effect relationship between CD34+ cell dose and time to recovery of both neutrophils or platelets. Predominantly CD34+ cells with the phenotype of myeloid precursors were mobilized. A minority of CD34+ cells expressed the erythroid and megakaryocytic lineage-associated antigens and a low but distinct population of CD34+ cells expressed antigens associated with multipotent stem cells. Analysis showed that the number of CD34+CD33- cells (r = -.74, P < .05), as well as the number of CD34+CD41+ cells (r = -.81, P < .005), correlated significantly better with time to neutrophil and platelet recovery, respectively, than with the total number of CD34+ cells (r = -.55 and r = -.56, respectively). CONCLUSION The numbers of CD34+CD33- cells and CD34+CD41+ cells may help to predict short-term repopulation capacity of PBSCs, especially when relatively low numbers of CD34+ cells per kilogram are reinfused.

[1]  S. Rodenhuis,et al.  Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  E. Ashihara,et al.  Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection. , 1994, Bone marrow transplantation.

[3]  M. Harada,et al.  Predominance of myeloid antigens in CD34‐positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony‐stimulating factor , 1994, European journal of haematology.

[4]  J. Peterse,et al.  Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer. , 1993, Annals of Oncology.

[5]  J. Down,et al.  Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. , 1993, Experimental hematology.

[6]  G. Leone,et al.  Further investigations on the expression of HLA‐DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34± haematopoietic progenitor cells , 1993, British journal of haematology.

[7]  W. Vainchenker,et al.  Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. , 1992, Blood.

[8]  S. Rodenhuis,et al.  Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Zhao,et al.  Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. , 1992, Blood.

[10]  I. Bernstein,et al.  CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons , 1992 .

[11]  L. To,et al.  Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. , 1992, Bone marrow transplantation.

[12]  L. To,et al.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.

[13]  I. Weissman,et al.  Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow , 1992, The Journal of experimental medicine.

[14]  K. Zsebo,et al.  Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. , 1991, Blood.

[15]  I. Bernstein,et al.  Blast colony-forming cells and precursors of colony-forming cells detectable in long-term marrow culture express the same phenotype (CD33- CD34+). , 1991, Experimental hematology.

[16]  L. To,et al.  Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. , 1991, Blood.

[17]  I. Bernstein,et al.  Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. , 1991, Blood.

[18]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[19]  P. Lansdorp,et al.  Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. , 1991, Blood.

[20]  J. Wagner,et al.  Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells , 1990, Nature.

[21]  C. Eaves,et al.  Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow , 1990, The Journal of experimental medicine.

[22]  R. Holle,et al.  Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Nakauchi,et al.  Colony formation of clone-sorted human hematopoietic progenitors. , 1990, Blood.

[24]  G. Bonadonna,et al.  Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Blood.

[25]  B. Haynes,et al.  Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Bernstein,et al.  Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties , 1989, The Journal of experimental medicine.

[27]  B. Asenbauer,et al.  Sequential expression of CD34 and CD33 antigens on myeloid colony‐forming cells , 1989, European journal of haematology.

[28]  R. Hoffman,et al.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. , 1988, The Journal of clinical investigation.

[29]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[30]  I. Bernstein,et al.  Antigen CD34+ marrow cells engraft lethally irradiated baboons. , 1988, The Journal of clinical investigation.

[31]  D. Weisenburger,et al.  Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. , 1988, Blood.

[32]  M R Loken,et al.  Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. , 1987, Blood.

[33]  L. To,et al.  CELL-DOSE EFFECT IN CIRCULATING STEM-CELL AUTOGRAFTING , 1986, The Lancet.

[34]  N. Gorin.  Collection, manipulation and freezing of haemopoietic stem cells. , 1986, Clinics in haematology.

[35]  J. Eliason,et al.  Isolation , 2024, Encyclopedia of Database Systems.

[36]  M. Greaves,et al.  Changes in cell surface antigen expression during hemopoietic differentiation. , 1982, Blood.

[37]  A. McMichael,et al.  Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. , 1982, Blood.

[38]  I. Weissman,et al.  Heterogeneity of hematopoietic stem cells. , 1993, Current opinion in immunology.

[39]  I. Bernstein,et al.  CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. , 1992, Blood.

[40]  W. Knapp.  Leucocyte typing IV : white cell differentiation antigens , 1989 .

[41]  Y. Lévy,et al.  Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. , 1989, Blood.

[42]  D. Weisenburger,et al.  High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. , 1989, Blood.

[43]  P. Celano,et al.  Two phases of engraftment established by serial bone marrow transplantation in mice. , 1989, Blood.

[44]  C. Civin,et al.  Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. , 1987, International journal of cell cloning.

[45]  C. Civin,et al.  Flow cytometric analysis of human bone marrow: I. Normal erythroid development. , 1987, Blood.

[46]  R. Andrews,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. , 1986, Blood.